Skip to main content
CT

Circadian Therapeutics

The startup develops therapeutics that target diseases linked to circadian rhythm disruptions by utilizing home-based ambulatory electroencephalogram devices for precise measurement of brain function. Their platform enables the creation of medical drugs that provide effective and safe treatments tailored to individual circadian patterns.

Oxford, United KingdomFounded 20163500+ followers
Updated 3 months ago

Funding

$8.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Many diseases are linked to disruptions in the body's natural circadian rhythm, but developing effective treatments is challenging due to the difficulty of precisely measuring individual brain function over extended periods in a real-world setting. Traditional methods often rely on infrequent, lab-based assessments that fail to capture the dynamic nature of circadian patterns.

Solution

This startup is developing therapeutics that target diseases linked to circadian rhythm disruptions. They utilize home-based ambulatory electroencephalogram (EEG) devices to continuously and precisely measure brain function in individuals' natural environments. This approach enables the creation of medical drugs that are tailored to individual circadian patterns, potentially leading to more effective and safer treatments. The platform aims to provide a more personalized and data-driven approach to addressing diseases associated with circadian rhythm imbalances.

Target Audience

The primary target audience includes pharmaceutical companies and researchers focused on developing treatments for diseases linked to circadian rhythm disruptions, as well as individuals suffering from such conditions.

Features

  • Home-based ambulatory EEG devices for continuous monitoring of brain function
  • Precise measurement of individual circadian patterns in real-world settings
  • Data-driven approach to drug development targeting circadian rhythm disruptions
  • Potential for personalized and more effective treatments
This profile is AI-generated and may contain inaccuracies.